The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study

Por Brekke, Kristin, Sommerfelt, Maja, Ökvist, Mats, Dyrhol-Riise, Anne Margarita, Kvale, Dag
Publicado no BMC Infect Dis (2017)

Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial

Por Brekke, Kristin, Lind, Andreas, Holm-Hansen, Carol, Haugen, Inger Lise, Sørensen, Birger, Sommerfelt, Maja, Kvale, Dag
Publicado no PLoS One (2014)

Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial

Por Huang, Yunda, Pantaleo, Giuseppe, Tapia, Gonzalo, Sanchez, Brittany, Zhang, Lily, Trondsen, Monica, Hovden, Arnt-Ove, Pollard, Richard, Rockstroh, Jürgen, Ökvist, Mats, Sommerfelt, Maja A.
Publicado no EBioMedicine (2017)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Por Søgaard, Ole S., Graversen, Mette E., Leth, Steffen, Olesen, Rikke, Brinkmann, Christel R., Nissen, Sara K., Kjaer, Anne Sofie, Schleimann, Mariane H., Denton, Paul W., Hey-Cunningham, William J., Koelsch, Kersten K., Pantaleo, Giuseppe, Krogsgaard, Kim, Sommerfelt, Maja, Fromentin, Remi, Chomont, Nicolas, Rasmussen, Thomas A., Østergaard, Lars, Tolstrup, Martin
Publicado no PLoS Pathog (2015)